ValiRx plc (LON:VAL – Get Free Report) traded down 9.6% during mid-day trading on Monday . The company traded as low as GBX 0.33 and last traded at GBX 0.33. 20,037,031 shares traded hands during mid-day trading, an increase of 222% from the average session volume of 6,219,320 shares. The stock had previously closed at GBX 0.37.
ValiRx Trading Down 0.7%
The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44. The business has a 50-day simple moving average of GBX 0.40 and a 200-day simple moving average of GBX 0.52. The company has a market cap of £1.12 million, a PE ratio of -0.32 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last issued its quarterly earnings data on Monday, September 29th. The company reported GBX (0.22) earnings per share for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. On average, analysts predict that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Read More
- Five stocks we like better than ValiRx
- Investing In Automotive Stocks
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- How to Capture the Benefits of Dividend Increases
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- Most Volatile Stocks, What Investors Need to Know
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
